For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Once enabled, click here to view the site.

singup link button why should I sign up?
Login as Volunteer Login as Study team member
OR

Studies you may be eligible for. 2

Based on the information you provided, we found the following studies.

  • Phase I/II Trial of experimental drug ganetespib in combination with the mTOR inhibitor sirolimus for patients with unresectable or metastatic malignant peripheral nerve sheath tumors (MPNST) Study purpose:find highest safe dose, side effects and any benefits of ganetespib when given with sirolimus; test whether 3D-MRI is better at seeing MPNST than traditional scans This study is researching all of the following topics: Cancerous bone tumor, Osteosarcoma Sarcoma This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • COG ADVL1211: A Phase 1 Study of XL184 in Children and Adolescents wish Recurrent or Refractory Solid Tumors, Including CNS Tumors Study drug XL184 (cabozatinib) works to inhibit or slow the growth of solid tumors by targeting the tumors which contain something called "tyrosine kinase". Pediatric solid tumor cancers, including brain tumors, are being studied. This study is researching all of the following topics: Brain cancer Cancerous bone tumor, Osteosarcoma NB, Neuroblastoma Sarcoma This study is looking for: male female both men and women Volunteers with specific conditions
    • 2 years to 21 years